Медицинская литература. Новинки

 

 

 

 

 

 

Фосфорная магнитно-резонансная спектроскопия печени (обзор литературы)

Вы можете загрузить полный текст статьи в формате pdf

На основе данных литературы представлена информация о разработке фосфорной магнитно-резонансной спектроскопии. Проанализированы современные возможности метода в диагностике как очаговых, так и диффузных заболеваний печени. Показана высокая информативность спектроскопии в изучении метаболизма печени на клеточном уровне. Вместе с тем отмечены определенные трудности и технические ограничения, стоящие на пути широкого внедрения метода в клиническую практику.

Ключевые слова:
печень, магнитный резонанс, магнитно-резонансная спектроскопия, гепатоцеллюлярный рак, метастазы, liver, MRI, 31P-MRS spectroscopy, HCC, MTS

Литература:
1.Ziparo V., Balducci G., Lucandi G., Mercantini P., Di Giacomo G., Fernandes E. Indications and results of resection for hepatocellular carcinoma. Eur. J. Surg. Oncol. 2002; 28 (7): 723-728.
2.Розенгауз Е.В. Роль компьютерной томографии в выборе тактики и оценке результатов лечения злокачественных опухолей печени: дис.. докт. мед. наук. СПб., 2008. 188 с.
3.Ивашкин В.Т., Буеверов О.А., Лапина Т.Л. Гастроэнтерология нового века: проблемы диагностики. Терапевтический архив. 2001; 73 (8): 33-36.
4.Ратников В.А. Высокопольная (1,5 Тл) магнитно-резонансная томография в диагностике неопухолевых заболеваний печени и желчных путей: дис.. докт. мед. наук. СПб., 2002. 404 с.
5.Vogl T.J., Lencioni R., Hammerstingl R.M., Bartolozzi C. Magnetic resonance imaging in liver disease. Stuttgart; New York: Georg Thieme Verlag, 2003. 260 p.
6.Ионин Б.И., Ершов Б.А., Кольцов А.И. ЯМР-спектроскопия в органической химии. Л.: Химия, 1983. 272 с.
7.Ринк П.А. Магнитный резонанс в медицине. М.: ГЭОТАР-МЕД, 2003. 256 с.
8.Неронов Ю.И., Гарайбех З. Ядерный магнитный резонанс в томографии и спектральных исследованиях: Учеб. пособие. СПб.: СПбГИТМО (ТУ), 2003. 104 с.
9.Поздняков А.В. Роль протонной магнитно-резонансной спектроскопии в диагностике заболеваний головного мозга: дис.. докт. мед. наук. СПб., 2001. 246 с.
10.Henderson T.O., Costello A.J.R., Omachi A. Phosphate metabolism in intact erythrocytes: determination phosphorus-31 nuclear magnetic resonance spectroscopy. Proc. Natl. Acad. Sci. USA. 1974; 71 (6): 2487-2490.
11.Moon R.B., Richards J.H. Determination of intracellular pH by 31P magnetic resonance. J. Biol. Chem. 1973; 248 (20): 7276-7278.
12.Styles P., Scott C.A., Radda G.K. A method for localizing high resolution NMR spectra from human subjects. Magn. Reson. Med. 1985; 2 (4): 402.
13.Maris J.M., Evans A.E., McLaughlin A.C., D’Angio G.J., Bolinger L., Manos H., Chance B. 31P NMR spectroscopic investigation of human neuroblastoma in situ. N. Engl. J. Med. 1985; 312 (23): 1500-1505.
14.Oberhaensli R.D., Galloway G.J., Taylor D.J., Bore P.J., Radda G.K. Assessment of human liver metabolism by phosphorus-31 magnetic resonance spectroscopy. Br. J. Radiol. 1986; 59 (703): 695-699.
15.Oberhaensli R.D., Galloway G.J., Taylor D.J., Bore P.J., Rajagopalan B., Radda G.K. First year of experience with P-31 magnetic resonance studies of human liver. Magn. Reson. Imaging. 1986; 4 (3): 413-416.
16.Damadian R. Tumor detection by nuclear magnetic resonance. Science. 1971; 171 (976): 1151-1153.
17.Hoult D.I., Busby S.J.W., Gadian D.G., Radda G.K., Richards R.E., Seeley PJ. Observations of tissue metabolites using phosphorus 31 nuclear magnetic resonance. Nature. 1974; 252 (5481): 285-287.
18.Matson G.B., Twieg D.B., Karczmar G.S. Application of imageguided surface coil P-31 MR spectroscopy to human liver, heart, and kidney. Radiology. 1988; 169 (2): 541-547.
19.Ban N., Moriyasu F., Tamada T., Kawasaki T., Son Ya., Nakamura T, Nishida O., Uchino H. In vivo P-31 MR spectroscopic studies of liver in normal adults and cirrhotic patients. RSNA (abstract). 1986; 161 (1): 340.
20.Meyerhoff D.J., Boska M.D., Thomas A.M., Weiner M.W. Alcoholic liver disease: quantitative image-guided 31P magnetic resonance spectroscopy. Radiology. 1990; 176 (2): 393-400.
21.Menon D.K., Harris M., Sargentoni J., Taylor-Robinson S.D., Cox I.J., Morgan M.Y. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcoholic abusters. Gastroenterology. 1995; 108 (3): 776-788.
22.Dezortova M., Taimr P., Skoch A., Spicak J., Hajek M. Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J. Gastroenterol. 2005; 28 (44): 6926-6931.
23.Lim A.K.P., Du Cane Rd., Patel N. The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology. 2003; 37 (4): 788-794.
24.Menon D.K., Sargentoni J., Taylor-Robinson S.D., Bell J.D., Bryant D.J., Coutts G.A., Rolles K., Burroughs A.K., Morgan M.Y. Effect of functional grade and ethiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis. Hepatology. 1995; 21 (2): 417-427.
25.Noren B., Dahlqvist O., Lundberg P., Almer S., Kechagias S., Ekstedt M., Franzen L., Wirell S., Smedby O. Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur. J. Radiol. 2008; 66 (2): 313-320.
26.Wu B., Song B., Zhou X.P., Yang Y., Lei X.Z., Jiang L.L. The relationship between 31P magnetic resonance spectroscopy and the histopathology of livers of chronic viral hepatitis patients. Zhonghua Gan Zang Bing Za Zhi. 2007; 15 (5): 338-341.
27.Chu W.C., Lam W.W., Lee K.H., Yeung D.K., Sihoe J., Yeung C.K. Phosphorus-31 MR spectroscopy in pediatric liver transplant recipients: a noninvasive assessment of graft status with correlation with liver function tests and liver biopsy. Am. J. Roentgenol. 2005; 184 (5): 1624-1629.
28.Taylor-Robinson S.D. Applications of magnetic resonance spectroscopy to chronic liver disease. Clin. Med. 2001; 1 (1): 54-60.
29.Taylor-Robinson S.D., Sargentoni J., Bell J.D., Thomas E.L., Marcus C.D., Changani K.K., Saeed N., Hodgson H.J., Davidson B.R., Burroughs A.K., Rolles K., Foster C.S., Cox I.J. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut. 1998; 42 (5): 735-743.
30.Wolf R.F., Haagsma E.B., Kamman R.L., Mooyaart E.L., Sluiter W.J., Sloof M.J. Noninvasive metabolic assessment of human donor livers: prognostic value of 31P-magnetic resonance spectroscopy for early graft function. Transplantation. 1997; 64 (1): 147-152.
31.Mann D.V., Lam W.W, Hjelm N.M., So N.M., Yeung D.K., Metreweli C., Lau W.Y. Human liver regeneration: hepatic energy economy is less efficient when the organ is diseased. Hepatology. 2001; 34 (3): 557-565.
32.Ljungberg M., Westberg G., Vikhoff-Baaz B., Starck G., Wangberg B., Ekholm S., Ahlman H., Forssell-Aronsson E. 31P MR spectroscopy to evaluate the efficacy of hepatic artery embolization in the treatment of neuroendocrine liver metastases. Acta Radiol. 2012; 53 (10): 1118-1126.
33.Qi J., Shukla-Dave A., Fong Y., Gonen M., Schwartz L.H., Jarnagin W.M., Koutcher J.A., Zakian K.L. 31P MR spectroscopic imaging detects regenerative changes in human liver stimulated by portal vein embolization. J. Magn. Reson. Imaging. 2011; 34 (2): 336-344.
34.Sun J.Z., Wang Z.K., Yu R.S., Huang L.S., Xu X.F., Zhang M.M. Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010; 39 (2): 150-156.
35.Dagnelie P.C., Leij-Halfwerk S. Magnetic resonance spectroscopy to study hepatic metabolism in diffuse liver diseases, diabetes and cancer. World J. Gastroenterol. 2010; 16 (13): 1577-1586.
36.Dagnelie P.C., Sijens P.E., Kraus D.J., Planting A.S., van Dijk P.V. Abnormal liver metabolism in cancer patients detected by (31)P MR spectroscopy. NMR Biomed. 1999; 12 (8): 535-544.
37.Khan S.A., Cox I.J., Hamilton G., Thomas H.C., Taylor-Robinson S.D. In vivo and in vitro nuclear magnetic resonance spectroscopy as a tool for investigating hepatobiliary disease: a review of H and P MRS applications. Liver Int. 2005; 25 (2): 273-281.
38.ter Voert E.G.W., Heijmen L., van Laarhoven H.W., Heerschap A. In vivo magnetic resonance spectroscopy of liver tumors and metastases. World J. Gastroenterol. 2011; 17 (47): 5133-5149.
39.Bogner W., Chmelik M., Andronesi O.C., Sorensen A.G., Trattnig S., Gruber S. In vivo 31P spectroscopy by fully adiabatic extended image selected in vivo spectroscopy: a comparison between 3 T and 7 T. Magn. Reson. Med. 2011; 66 (4): 923-930.
40.Sevastianova K., Hakkarainen A., Kotronen A., Corner A., Arkkila P., Arola J., Westerbacka J., Bergholm R., Lundbom J., Lundbom N., Yki-Jarvinen H. Nonalcoholic fatty liver disease: detection of elevated nicotinamide adenine dinucleotide phosphate with in vivo 3.0-T 31P MR spectroscopy with proton decoupling. Radiology. 2010; 256 (2): 466-473.
41.Wylezinska M., Cobbold J.F., Fitzpatrick J., McPhail M.J., Crossey M.M., Thomas H.C., Hajna J.V., Vennart W., Cox I.J., Taylor-Robinson S.D. A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states. NMR Biomed. 2011; 24 (3): 231-237.
42.Bauer A., Schumann A., Gilbert M., Wilhelm C., Hengstler J.G., Schiller J., Fuchs B. Evaluation of carbon tetrachloride-induced stress on rat hepatocytes by 31P NMR and MALDI-TOF mass spectrometry: lysophosphatidylcholine generation from unsaturated phosphatidylcholines. Chem. Phys. Lipids. 2009; 159 (1): 21-29.
43.Corbin I.R., Buist R., Peeling J., Zhang M., Uhanova J., Minuk G.K. Utility of hepatic phosphorus-31 magnetic resonance spectroscopy in a rat model of acute liver failure. J. Investig. Med. 2003; 51 (1): 42-49.
44.Landis C.S., Yamanouchi K., Zhou H., Mohan S., Roy-Chowdhury N., Shafritz D.A., Koretsky A., Roy-Chowdhury J., Hetherington H.P., Guha C. Noninvasive evaluation of liver repopulation by transplanted hepatocytes using 31P MRS imaging in mice. Hepatology. 2006; 44 (5): 1250-1258.
45.Li Z.J., Ma Y.H., Liu Q., Wang S.Q., Wang N., Li B.P, Chen J., Yang J.Y., Liu Y.B., Liang C.H. Experimental study on monitoring gene expression by noninvasive method in rabbit VX2 liver tumor model. Zhonghua Gan Zang Bing Za Zhi. 2010; 18 (12): 905-908.
46.Xu X.F., Yu R.S., Liu R., Sun J.Z., Chen Y.H., Chen J., Zhang M.M. Biochemical metabolic changes detected by phosphorus-31 MR spectroscopy in liver of fasting rabbits. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2010; 39 (2): 143-149.
47.Yu R.S., Hao L., Dong F., Mao J.S., Sun J.Z., Chen Y., Lin M., Wang Z.K., Ding W.H. Biochemical metabolic changes assessed by 31P magnetic resonance spectroscopy after radiation-induced hepatic injury in rabbits. World J. Gastroenterol. 2009; 15 (22): 2723-2730.
48.Solga S.F., Horska A., Clark J.M., Diehl A.M. Hepatic 31P magnetic resonance spectroscopy: a hepatologist''s user guide. Liver Int. 2005; 25 (3): 490-500.
49.Sijens P.E. Parametric exploration of the liver by magnetic resonance methods. Eur. Radiol. 2009; 19 (11): 2594-2607.
50.Corbin I.R., Ryner L.N., Singh H., Minuk G.Y. Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2004; 287 (2): 379-384.
51.Godfrey E.M., Patterson A.J., Priest A.N., Davies S.E., Joubert I., Krishnan A.S., Griffin N., Shaw A.S., Alexander G.J., Allison M.E., Griffiths W.J., Gimson A.E., Lomas D.J. Acomparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur. Radiol. 2012; 22 (12): 2790-2797.

Phosphorus Magnetic Resonance Hepatic Spectroscopy (review)

This review provides literature-based information on the development of phosphorus-31 magnetic resonance spectroscopy method. Current state and potential of this technique to diagnose focal and diffuse liver lesions were analyzed. Magnetic resonance spectroscopy was shown to be highly informative for cellular-level liver metabolism research. The review also highlights certain difficulties and technical limitations which impede the extensive use of spectroscopy in clinical practice.

Keywords:
печень, магнитный резонанс, магнитно-резонансная спектроскопия, гепатоцеллюлярный рак, метастазы, liver, MRI, 31P-MRS spectroscopy, HCC, MTS